Virtus ETF Advisers »

Bridgebio Pharma shares owned by Virtus ETF Advisers

Quarter-by-quarter ownership of Bridgebio Pharma shares owned by Virtus ETF Advisers from 13F filings

Historical chart of Virtus ETF Advisers investment in Bridgebio Pharma

Tip: Access up to 7 years of quarterly data

All positions including Bridgebio Pharma held by Virtus ETF Advisers consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Bridgebio Pharma by Virtus ETF Advisers

Quarter filed Position value Share count Share price at filing
2026-06-30 $32k 18k 1.78

More positions owned by Virtus ETF Advisers

Virtus Etf Tr Ii Us Dividend Etf (VUS)
Virtus Etf Tr Ii Intl Divd Etf (VDI)
Virtus Etf Tr Ii Virtus Em Mkts (VEM)
Credicorp (BAP)
Ssr Mining (SSRM)
Centerra Gold (CGAU)
Lam Research Corp Com New (LRCX)
Tower Semiconductor Shs New (TSEM)
Apple (AAPL)
Grupo Cibest Sa Spon Ads (CIB)
Ishares Msci Taiwan Etf (EWT)
Applied Materials (AMAT)
Penguin Solutions (PENG)
Open Text Corp (OTEX)
Te Connectivity Ord Shs (TEL)

View all positions for Virtus ETF Advisers

Top funds holding Bridgebio Pharma

Wolverine Asset Management
Steelhead Partners
Capstone Investment Advisors
DeepCurrents Investment Group
Moore Capital Management
Aristeia Capital
Lazard Asset Management
Graham Capital Management
683 Capital Management
Millennium Management
Bnp Paribas Arbitrage, Snc
Bank of America Corporation
State Street Corporation
M&G
BlackRock

View all funds holding Bridgebio Pharma